Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy

Clinical trial NCT05369793 · COMPLETED

Trial details

NCT number: NCT05369793
Sponsor: Tanta University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes (Adult Onset)Diabetic Neuropathies

Start date: 2022-08-01
Primary completion: 2023-10-10
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.